Sponsor Pipeline

Kexing Biopharm Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
3
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07553351 GB06 Phase III Trial for Pediatric Growth Hormone Deficiency Growth Hormone Deficiency (GHD) Recruiting
NCT06363370 Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children… Respiratory Syncytial Virus Infections Recruiting
NCT06711523 Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy Neutropenia, Chemotherapy-Induced Febrile Active, Not Recruiting
Phase 1
NCT07519564 A Phase I Clinical Study to Evaluate the Efficacy and Safety of GB18 Injection in… Cachexia; Cancer Recruiting
Disease Areas
Get alerts when Kexing Biopharm Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free